Product Name: Omarigliptin CAS NO:1226781-44-7
Chemical & Physical Properties:
Appearance : White powder
Boiling Point:529.4℃ at 760 mmHg
Flash Point:274.0±32.9 ℃
Augagliptin (MK-3102) is an ultra-long-acting dipeptidyl peptidase-4 (DPP-4) inhibitor, an oral hypoglycemic agent developed by Merck & Co., once a week. It can produce continuous DPP. -4 Inhibition, has a brand-new blood sugar lowering mechanism, and has the advantages of not increasing weight, not causing hypoglycemia, and not causing edema. The mechanism of action is by inhibiting the degradation of glucagon-like peptide-1 (GLP-1) by DPP-4 enzyme in the body, prolonging the action time of GLP-1, thereby increasing the endogenous GLP-1 and GIP in the blood Concentration, and ultimately improve blood sugar control.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.